Vabysmo 6 MG/0.05 ML vial 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSGY4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,488
Award facts
- Contract value 100% obligated
- $1,488.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,488.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply chains for the Department of Defense.
DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical system, with the parent IDC (contract SPE2DR) valued at $499,999,999 and extending through December 31, 2036. The company's comprehensive product portfolio spans branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to fulfill diverse pharmaceutical requirements across Department of Defense healthcare facilities worldwide. As a PPV-G GEN V regional prime vendor contractor, DMS Pharmaceutical Group's demonstrated performance on numerous delivery orders reflects its capability to support recurring medical supply needs of the military healthcare system with specialized pharmaceutical products including oncology treatments, immunosuppressants, and emergency medications.
Quick answers
Who was awarded contract SPE2DR26FSGY4?
SPE2DR26FSGY4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FSGY4 worth?
The government has obligated $1,488 on SPE2DR26FSGY4.
Is contract SPE2DR26FSGY4 an order under another contract?
Yes. SPE2DR26FSGY4 is a delivery order under SPE2DR25D9305, an indefinite delivery contract.
Was contract SPE2DR26FSGY4 competed?
The extent of competition for SPE2DR26FSGY4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award